I am a Postdoctoral Researcher working with Professor Philip McGuire in the Precision Psychiatry research group. My interests lie in prevention of psychosis and other severe mental disorders, particularly in combining prediction modelling methods with routinely collected data to improve identification of individuals at risk, predict their clinical outcomes and their response to interventions.
My main role involves biomarker acquisition and analysis on the Stratification and Treatment in Early Psychosis (STEP) programme. STEP is three large scale, international multi-centre clinical trials of cannabidiol (CBD) in different stages of early psychosis: 1) Clinical high risk for psychosis; 2) First episode psychosis and; 3) Treatment resistant psychosis.
I completed my PhD in 2022 ("Improving prediction of psychosis risk") at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, under the supervision of Professor Paolo Fusar-Poli and Professor Philip McGuire. In addition to colleagues at University of Oxford, I have continued collaborations at King's College London.